---
title: "LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026 | LMAT Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275624823.md"
description: "LeMaitre Vascular, Inc. (Nasdaq:LMAT) will announce its fourth quarter 2025 earnings results on February 25, 2026, after market close. A conference call is scheduled for 5:00 PM EST the same day to discuss the results and company outlook. Registrants will receive dial-in information for the live call, which will also be available via audio webcast. LeMaitre specializes in devices for treating peripheral vascular disease, impacting over 200 million people globally."
datetime: "2026-02-11T06:47:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275624823.md)
  - [en](https://longbridge.com/en/news/275624823.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275624823.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275624823.md) | [繁體中文](https://longbridge.com/zh-HK/news/275624823.md)


# LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026 | LMAT Stock News

BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at www.lemaitre.com/investor.

**About LeMaitre**

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

  
  

Contact:Gregory MankerDirector, Business Development & Investor RelationsLeMaitre Vascular, Inc.+ 1-781-362-1260gmanker@lemaitre.com

### Related Stocks

- [LeMaitre Vascular, Inc. (LMAT.US)](https://longbridge.com/en/quote/LMAT.US.md)

## Related News & Research

- [A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K](https://longbridge.com/en/news/280880388.md)
- [LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/275199312.md)
- [Navient to announce first quarter 2026 results, host earnings webcast April 29 | NAVI Stock News](https://longbridge.com/en/news/281641040.md)
- [TFI International Sets Date for First-Quarter 2026 Earnings Release and Webcast](https://longbridge.com/en/news/281074254.md)
- [Alaska Air Group announces webcast of first quarter 2026 financial results | ALK Stock News](https://longbridge.com/en/news/281261683.md)